According to the latest report by IMARC Group, titled "Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025," the global regenerative medicine market grew at a CAGR of around 16% during 2014-2019. Regenerative medicines refer to an interdisciplinary field that plays a vital role in tissue and organ transplants. It uses stem cells developed in laboratories to potentially replace damaged cells or stimulate the body’s repair mechanism in an attempt to regenerate human cells, tissues or organs to restore normal function of the damaged parts. Apart from being applied for restoring the structure and function of diseased and injured tissues and organs, they can also be utilized by scientists for applications in cell therapy, gene therapy and tissue engineering. As a result, it is widely being used across the oncology, cardiology, dermatology and ophthalmology segments of the healthcare sector.
Get a sample copy of this Report: https://www.imarcgroup.com/regenerative-medicine-market/requestsample
Global Regenerative Medicine Market Trends:
The market is primarily driven by the increasing prevalence of chronic medical ailments and genetic disorders across the globe. Stem cells are widely being used for treating various conditions, including arthritis and Parkinson’s disease, as they offer the possibility of regenerating the diseased cells and organs. This has provided a boost to the applications of regenerative medicines, thereby providing a thrust to the market growth. Moreover, there has been a significant increase in the geriatric population on the global level. The elderly are more prone to developing numerous health conditions, such as oncological, dermatological and cardiological disorders, while having higher chances of requiring organ transplantation. Regenerative medicines find extensive applications in organ transplantation as their usage is expected to minimize the risk of organ rejection by the body after the transplant while considerably improving the recovery speed of the patient. The market is further driven by technological advancements in regenerative medicines, which have led to the advent of 3D bioprinting and stem cell treatments for vision loss and heart repair. This is being supported by the increasing investments in research and development (R&D) by various private and government organizations. The advancements in biologics, stem cell-based therapies and tissue engineering are further expected to drive the market growth. Some of the other factors creating a positive outlook for the market include the increasing number of clinical trials and significant developments in the healthcare infrastructure. On account of the aforementioned factors, the market is anticipated to witness strong growth during 2020-2025.
Market Summary:
- On the basis of the type, the market has been divided into stem cell therapy, biomaterial, tissue engineering and others.
- Based on the application, the market has been classified into bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, central nervous system and others.
- On the basis of the end user, the market has been categorized into hospitals, specialty clinics and others.
- On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
- The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players Allergan plc (AbbVie Inc.), Amgen Inc., Baxter International, Inc., BD (Becton, Dickinson and Company), Integra LifeSciences Corporation, Medtronic plc, MiMedx Group, Inc., Novartis AG, Osiris Therapeutics, Inc. (Smith & Nephew plc), and Thermo Fisher Scientific Inc.
View Full Report with TOC & List of Figure: https://bit.ly/3qsSq1L
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Note: We are updating our research reports 2021-2026, if you need our research report with business model visit us.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
USA: +1-631-791-1145
Email: [email protected]
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal
Regenerative medicine market is expected to gain market growth in the forecast period of 2020 to 2027.
Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period.
Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.The growth of regenerative medicine market enhanced by the growing cases of chronic diseases and rise in research and development activities conducted by many pharmaceuticals’ companies.
In addition, advances in the technology and adoption of stem cell therapies are some of the impacting factors for the demand of regenerative drugs.
Nevertheless, huge financial burden coupled with stringent regulatory framework are the factors that hinder the growth of this market.Get Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-regenerative-medicine-marketMarket Drivers and Restraints:On the basis of technology, the regenerative medicine market is segmented into stem cell therapy, biomaterial, tissue engineering and others.Based on application, the regenerative medicine market is segmented into bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular and others.On the basis of end-users, the regenerative medicine market is segmented into hospitals, specialty clinics and others.On the basis of distribution channel, the regenerative medicine market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.The major players covered in the Regenerative Medicine Market ForecastedThe major players covered in the global regenerative medicine market are Integra LifeSciences Corporation, MiMedx Group, Inc, AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc.,Organogenesis Inc., Osiris Therapeutics, Inc., Vericel Corporation, and NuVasive, Inc., Acelity (KCI Concepts) (U.S.), Cook Biotech Inc., Novartis AG, Vericel Corporation, U.S.
Stem Cell, Athersys, Inc., CryoLife, Inc and others.Major TOC Of The ReportChapter One: Regenerative Medicine Market Forecasted OverviewChapter Two: Manufacturers ProfilesChapter Three: Global Regenerative Medicine Market Competition, by PlayersChapter Four: Global Regenerative Medicine Market Forecasted Size by RegionsChapter Five: North AmericaRegenerative Medicine Market Forecasted Revenue by CountriesChapter Six: Europe Regenerative Medicine Market Forecasted Revenue by CountriesChapter Seven: Asia-Pacific Regenerative Medicine Market Forecasted Revenue by CountriesChapter Eight: South America Regenerative Medicine Market Forecasted Revenue by CountriesTo Know More Visit To Report @https://www.databridgemarketresearch.com/toc/?dbmr=global-regenerative-medicine-marketKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the global Regenerative Medicine Market ForecastedAnalysis of market effect factors and their impact on the forecast and outlook of the global Regenerative Medicine Market ForecastedThe detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Regenerative Medicine Market ForecastedA roadmap of growth opportunities available in the global Regenerative Medicine Market Forecasted with the identification of key factorsThe exhaustive analysis of various trends of the global Regenerative Medicine Market Forecasted to help identify market developmentsKey Questions Answered in Report:What is the key to the Regenerative Medicine Market Forecasted ?What will the Regenerative Medicine Market Forecasted Demand and what will be Growth?What are the latest opportunities for Regenerative Medicine Market Forecasted in the future?What are the strengths of the key players?Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart) @https://www.databridgemarketresearch.com/reports/global-regenerative-medicine-marketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
